|
Published: November 15, 2021
Oral PCSK9 inhibitor found to be safe, effective to lower cholesterol, in first human trial
American Heart Association Scientific Sessions 2021, LBS.06
This link is provided for convenience only and is not an endorsement of either the linked-to entity or any product or service.